Citation: | WU Shu-lu, NIU Kai-xuan, XU Yang, LIU Cheng, DENG Xi-ming. Effects of antiplatelet therapy on inflammatory response, platelet function and therapeutic effect of sepsis[J]. Chinese Journal of General Practice, 2022, 20(8): 1311-1314. doi: 10.16766/j.cnki.issn.1674-4152.002584 |
[1] |
SINGER M, DEUTSCHMAN C S, SEYMOUR C W, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3)[J]. JAMA, 2016, 315(8): 801-810. doi: 10.1001/jama.2016.0287
|
[2] |
WANG Y H, OUYANG Y Q, LIU B Y, et al. Platelet activation and antiplatelet therapy in sepsis: A narrative review[J]. Thromb Res, 2018, 166: 28-36. doi: 10.1016/j.thromres.2018.04.007
|
[3] |
KIERS D, VAN DER HEIJDEN WA, VAN EDE L, et al. A randomised trial on the effect of anti-platelet therapy on the systemic inflammatory response in human endotoxaemia[J]. Thromb Haemost, 2017, 117(9): 1798-1807. doi: 10.1160/TH16-10-0799
|
[4] |
OSTHOFF M, SIDLER J A, LAKATOS B, et al. Low-dose acetylsalicylic acid treatment and impact on short-term mortality in staphylococcus aureus bloodstream infection: A propensity score-matched cohort study[J]. Crit Care Med, 2016, 44(4): 773-781. doi: 10.1097/CCM.0000000000001554
|
[5] |
吴晓飞. 脓毒症的诊断和治疗[J]. 中华全科医学, 2014, 12(10): 1538-1539. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201410002.htm
WU X F. Diagnosis and treatment of sepsis[J]. Chinese Journal of General Practice, 2014, 12(10): 1538-1539. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201410002.htm
|
[6] |
VARDON-BOUNES F, RUIZ S, GRATACAP M P, et al. Platelets are critical key players in sepsis[J]. Int J Mol Sci, 2019, 20(14): 3494. doi: 10.3390/ijms20143494
|
[7] |
王怡宁, 汪松, 陆元兰, 等. 血小板在脓毒症及其所致器官功能障碍发病中作用的研究进展[J]. 山东医药, 2018, 58(30): 100-102. doi: 10.3969/j.issn.1002-266X.2018.30.029
WANG Y N, WANG S, LU Y L, et al. Research progress on the role of platelets in the pathogenesis of sepsis and organ dysfunction[J]. Shandong Medical Journal, 2018, 58(30): 100-102. doi: 10.3969/j.issn.1002-266X.2018.30.029
|
[8] |
KIM S J, DAVIS R P, JENNE C N. Platelets as modulators of inflammation[J]. Semin Thromb Hemost, 2018, 44(2): 91-101. doi: 10.1055/s-0037-1607432
|
[9] |
HANNACHI N, OGÉ-GANAYE E, BAUDOIN J P, et al. Antiplatelet agents have a distinct efficacy on platelet aggregation induced by infectious bacteria[J]. Front Pharmacol, 2020, 11: 863. doi: 10.3389/fphar.2020.00863
|
[10] |
POORANI R, BHATT A N, DWARAKANATH B, et al. COX-2, Aspirin and metabolism of arachidonic, eicosapentaenoic and docosahexaenoic acids and their physiological and clinical significance[J]. Eur J Pharmacol, 2016, 785: 116-132. doi: 10.1016/j.ejphar.2015.08.049
|
[11] |
JAIN N, PHADNIS M A, MARTIN B C, et al. Potent antiplatelet therapy may reduce death from sepsis in patients on chronic dialysis[J]. Am J Cardiol, 2022, 162: 209-211. doi: 10.1016/j.amjcard.2021.10.001
|
[12] |
HAMID U KRASNODEMBSKAYA A, FITZGERALD M, et al. Aspirin reduces lipopolysaccharide-induced pulmonary inflammation in human models of ARDS[J]. Thorax, 2017, 72(11): 971-980. doi: 10.1136/thoraxjnl-2016-208571
|
[13] |
CASEY J D, SEMLER M W, BASTARACHE J A, et al. Aspirin for sepsis prophylaxis: An ounce of prevention?[J]. Crit Care Med, 2017, 45(11): 1959-1960. doi: 10.1097/CCM.0000000000002669
|
[14] |
WIEWEL M A, DE STOPPELAAR S F, VAN VUGHT L A, et al. Chronic antiplatelet therapy is not associated with alterations in the presentation, outcome, or host response biomarkers during sepsis: A propensity-matched analysis[J]. Intensive Care Med, 2016, 42(3): 352-360. doi: 10.1007/s00134-015-4171-9
|
[15] |
AL HARBI S A, TAMIM H M, AL-DORZI H M, et al. Association between Aspirin therapy and the outcome in critically ill patients: A nested cohort study[J]. BMC Pharmacol Toxicol, 2016, 17: 5. doi: 10.1186/s40360-016-0047-z
|
[16] |
EIZAYAGA F X, BELON P, DESPLAT V, et al. Effects of ultra-low-dose Aspirin in thrombosis and haemorrhage[J]. Homeopathy, 2019, 108(3): 158-168. doi: 10.1055/s-0038-1677495
|
[17] |
徐波. 血小板聚集率、血小板功能在评价脓毒症患者预后的价值[J]. 血栓与止血学, 2020, 26(6): 953-955. doi: 10.3969/j.issn.1009-6213.2020.06.022
XU B. The value of platelet aggregation rate and platelet function in evaluating the prognosis of sepsis[J]. Chinese Journal of Thrombosis and Hemostasis, 2020, 26(6): 953-955. doi: 10.3969/j.issn.1009-6213.2020.06.022
|
[18] |
姜丽静, 倪金迪, 李何昊, 等. 血栓弹力图指导抗血小板治疗在冠状动脉支架植入术后患者中的应用[J]. 血栓与止血学, 2022, 28(4): 541-542, 545. https://www.cnki.com.cn/Article/CJFDTOTAL-XSZX202203082.htm
JIANG J L, NI J D, LI H H, et al. Thromboelastography to guide the application of antiplatelet therapy in patients after coronary artery stent implantation[J]. Chinese Journal of Thrombosis and Hemostasis, 2022, 28(4): 541-542, 545. https://www.cnki.com.cn/Article/CJFDTOTAL-XSZX202203082.htm
|